Stockholders' Equity (Details Textual) - USD ($)		1 Months Ended	6 Months Ended	12 Months Ended
Stockholders' Equity (Details Textual) - USD ($)	Oct. 12, 2018	Jul. 23, 2018	Jun. 30, 2019	Dec. 31, 2018	Mar. 31, 2019	Sep. 19, 2017
Stockholders' Equity (Textual)
Reverse stock split, description		The Company effected a 1-for-1,000 reverse stock split of its issued and outstanding common stock. The number of shares of common stock issued and outstanding post- reverse stock split is 1,404,073.
Increase in additional paid-in-capital				$ 140,169
Common stock, shares authorized			4,000,000,000	4,000,000,000
Common stock, par value			$ 0.0001	$ 0.0001
Common stock, shares outstanding			13,441,875	3,482,840
Common stock, shares issued			13,441,875	3,482,840
Convertible preferred, stock description	The Company filed with the State of Nevada a certificate of designation pursuant to which the Company designated a new class of preferred stock as the Company's Series C Convertible Preferred Stock ("Series C Preferred") having a $100.00 stated value per share ("Stated Value") and a par value equal to $0.0001 per share. The Company designated 5,000 shares of Series C Preferred. Subject to a beneficial ownership limitation equal to 4.99%, each share of Series C Preferred is convertible into 25,000 shares of the Company's common stock.		At December 31, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at December 31, 2016. The Series B preferred stock has no voting rights. During the quarter ended March 31, 2017, 18,100 shares of Series B preferred shares were converted into common stock in accordance with the terms of the Series B preferred stock. As of result there were 8,000 shares of Series B preferred shares outstanding at June 30, 2019 and December 31, 2018. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Common Stock [Member]
Stockholders' Equity (Textual)
Common stock, shares authorized						4,000,000,000
Series C Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			5,000	5,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			338	177
Preferred stock, shares outstanding			338	177
Preferred stock stated value			$ 33,800	$ 17,700
Preferred shares issued to professionals, value			$ 23	$ 204,212
Preferred shares issued to professionals, shares			36,163
Series A Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			1,000,000	1,000,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			500,000	500,000
Preferred stock, shares outstanding			500,000	500,000
Preferred stock has preferential voting rights			The preferred stock has preferential voting rights of 2,000 votes per outstanding share.
Series B Convertible Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized			50,000	50,000
Preferred stock, par value			$ 0.0001	$ 0.0001
Preferred stock, shares issued			8,000	8,000
Preferred stock, shares outstanding			8,000	8,000
Series B convertible Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, par value					$ 0
Preferred stock, shares issued					315
Preferred stock, shares outstanding					315
Preferred stock stated value					$ 31,500
Preferred shares issued to professionals, value					$ 184,506
Preferred shares issued to professionals, shares					138

Medifirst Solutions, Inc. 10-Q